Apolipoprotein E Codetermines Tissue Tropism of Hepatitis C Virus and Is Crucial for Viral Cell-to-Cell Transmission by Contributing to a Postenvelopment Step of Assembly
暂无分享,去创建一个
Lars Kaderali | Juliane Doerrbecker | L. Kaderali | T. Pietschmann | B. Wölk | D. Bankwitz | Thomas Pietschmann | Benno Wölk | Kathrin Hueging | Mandy Doepke | Gabrielle Vieyres | Dorothea Bankwitz | Anne Frentzen | Frauke Gumz | Sibylle Haid | S. Haid | J. Doerrbecker | G. Vieyres | K. Hueging | M. Doepke | A. Frentzen | F. Gumz
[1] Raymond T Chung,et al. Apolipoprotein B–dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin , 2008, Hepatology.
[2] F. Zoulim,et al. Very-Low-Density Lipoprotein (VLDL)-Producing and Hepatitis C Virus-Replicating HepG2 Cells Secrete No More Lipoviroparticles than VLDL-Deficient Huh7.5 Cells , 2013, Journal of Virology.
[3] S. Pfeffer,et al. Reconstitution of the Entire Hepatitis C Virus Life Cycle in Nonhepatic Cells , 2012, Journal of Virology.
[4] Robert J. Linhardt,et al. Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate* , 2003, Journal of Biological Chemistry.
[5] A. Burt,et al. Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients , 2006, Journal of Virology.
[6] T. Pietschmann,et al. Entry and replication of recombinant hepatitis C viruses in cell culture. , 2013, Methods.
[7] Sangeeta N. Bhatia,et al. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system , 2010, Nature Biotechnology.
[8] Toshiaki Maruyama,et al. Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.
[9] M. Imamura,et al. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor , 2011, Nature Medicine.
[10] M. Hiet,et al. Mouse hepatic cells support assembly of infectious hepatitis C virus particles. , 2011, Gastroenterology.
[11] Thomas Lengauer,et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. , 2011, Cell host & microbe.
[12] L. Seeff,et al. Natural history of chronic hepatitis C , 2002, Hepatology.
[13] J. Dubuisson,et al. Role of low‐density lipoprotein receptor in the hepatitis C virus life cycle , 2012, Hepatology.
[14] H. Tillmann,et al. Hepatitis C virus infection and the brain , 2004, Metabolic Brain Disease.
[15] C. Rice,et al. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells , 2009, The Journal of general virology.
[16] D. Lavanchy,et al. Evolving epidemiology of hepatitis C virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[17] S. Emerson,et al. Apolipoprotein C1 Association with Hepatitis C Virus , 2008, Journal of Virology.
[18] Benjamin Israelow,et al. HepG2 Cells Expressing MicroRNA miR-122 Support the Entire Hepatitis C Virus Life Cycle , 2011, Journal of Virology.
[19] R. Bartenschlager,et al. Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses , 2006, Journal of Virology.
[20] C. Rice,et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Rowe,et al. Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. , 2001, Virology.
[22] J. McLauchlan,et al. Sequence motifs required for lipid droplet association and protein stability are unique to the hepatitis C virus core protein. , 2000, The Journal of general virology.
[23] D. Lavillette,et al. The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus , 2008, Journal of Virology.
[24] Sangeeta N Bhatia,et al. Modeling hepatitis C virus infection using human induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.
[25] F. Penin,et al. Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions , 2007, PLoS pathogens.
[26] F. Chisari,et al. Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion , 2007, Journal of Virology.
[27] M. Gale,et al. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. , 2009, Virology.
[28] D. Trono,et al. Lentiviral Vectors Interfering with Virus-Induced CD4 Down-Modulation Potently Block Human Immunodeficiency Virus Type 1 Replication in Primary Lymphocytes , 2004, Journal of Virology.
[29] Charles M. Rice,et al. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus , 2012, Proceedings of the National Academy of Sciences.
[30] L. Kaderali,et al. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver‐derived cells , 2014, Hepatology.
[31] Xianfang Wu,et al. Hepatitis C Virus Attachment Mediated by Apolipoprotein E Binding to Cell Surface Heparan Sulfate , 2012, Journal of Virology.
[32] R. Thomssen,et al. Association of hepatitis C virus in human sera with beta-lipoprotein. , 1992, Medical microbiology and immunology.
[33] M. Mizokami,et al. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. , 2003, Gastroenterology.
[34] G. Thomson. A direct deduction of the constant process used in the method of right and wrong cases. , 1919 .
[35] M. Harada,et al. High‐density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus , 2003, Journal of medical virology.
[36] R. Bartenschlager,et al. The lipid droplet is an important organelle for hepatitis C virus production , 2007, Nature Cell Biology.
[37] Jieyun Jiang,et al. Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture , 2007, Journal of Virology.
[38] L. Kaderali,et al. Hepatitis C Virus p7 is Critical for Capsid Assembly and Envelopment , 2013, PLoS pathogens.
[39] G. Kärber,et al. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche , 1931, Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie.
[40] J. McKeating,et al. Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors. , 2011, Journal of hepatology.
[41] N. Heaton,et al. Molecular Determinants and Dynamics of Hepatitis C Virus Secretion , 2012, PLoS pathogens.
[42] J. McKeating,et al. Hepatitis C virus cell‐cell transmission in hepatoma cells in the presence of neutralizing antibodies , 2007, Hepatology.
[43] L. Kaderali,et al. MAP-Kinase Regulated Cytosolic Phospholipase A2 Activity Is Essential for Production of Infectious Hepatitis C Virus Particles , 2012, PLoS pathogens.
[44] Céline Hernandez,et al. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. , 2010, Gastroenterology.
[45] R. Thomssen,et al. Association of hepatitis C virus in human sera with β-lipoprotein , 2004, Medical Microbiology and Immunology.
[46] Charles M. Rice,et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells , 2009, Nature.
[47] Jinhong Chang,et al. Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells , 2008, Journal of Virology.
[48] C. Spearman,et al. The method of 'right and wrong cases' ('constant stimuli') without Gauss's formulae , 1908 .
[49] A. Shavinskaya,et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[50] B. Lindenbach. Virion assembly and release. , 2013, Current topics in microbiology and immunology.
[51] Philip Roelandt,et al. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. , 2012, Journal of hepatology.
[52] R. Bartenschlager,et al. Efficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles , 2008, Journal of Virology.
[53] Liang-Tzung Lin,et al. Replication of Subgenomic Hepatitis C Virus Replicons in Mouse Fibroblasts Is Facilitated by Deletion of Interferon Regulatory Factor 3 and Expression of Liver-Specific MicroRNA 122 , 2010, Journal of Virology.
[54] A. Moorman,et al. The osmolarity of the electroporation medium affects the transient expression of genes. , 1990, Nucleic acids research.
[55] S. Lemon,et al. Liver injury and disease pathogenesis in chronic hepatitis C. , 2013, Current topics in microbiology and immunology.
[56] D. Trono,et al. A Third-Generation Lentivirus Vector with a Conditional Packaging System , 1998, Journal of Virology.
[57] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[58] T. Pietschmann,et al. Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles* , 2009, The Journal of Biological Chemistry.
[59] P. Sarnow,et al. Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.
[60] V. Agnello,et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[61] L. Kaderali,et al. Isolate‐dependent use of claudins for cell entry by hepatitis C virus , 2014, Hepatology.
[62] M. Hiet,et al. Biochemical and Morphological Properties of Hepatitis C Virus Particles and Determination of Their Lipidome* , 2010, The Journal of Biological Chemistry.
[63] A. Zignego,et al. Hepatitis C virus lymphotropism: lessons from a decade of studies. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[64] A. Thiele,et al. Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins , 1993, Medical Microbiology and Immunology.
[65] T. Baumert,et al. Hepatitis C virus entry. , 2013, Current topics in microbiology and immunology.
[66] B. Lindenbach,et al. Trafficking of Hepatitis C Virus Core Protein during Virus Particle Assembly , 2011, PLoS pathogens.
[67] R. De Francesco,et al. Hepatitis C virus-specific directly acting antiviral drugs. , 2013, Current topics in microbiology and immunology.
[68] G. Duverlie,et al. Cell culture systems for the hepatitis C virus. , 2007, World journal of gastroenterology.
[69] C. Englert,et al. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. , 1996, Virology.
[70] David M. Gilbert,et al. Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation , 2012, PLoS pathogens.
[71] William J. Rice,et al. Ultrastructural analysis of hepatitis C virus particles , 2013, Proceedings of the National Academy of Sciences.
[72] S. Uprichard,et al. Identification of transferrin receptor 1 as a hepatitis C virus entry factor , 2013, Proceedings of the National Academy of Sciences.
[73] Xijun Song,et al. Claudin-6 and Claudin-9 Function as Additional Coreceptors for Hepatitis C Virus , 2007, Journal of Virology.
[74] M. Gale,et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins , 2007, Proceedings of the National Academy of Sciences.
[75] M. Manns,et al. Impact of Intra- and Interspecies Variation of Occludin on Its Function as Coreceptor for Authentic Hepatitis C Virus Particles , 2011, Journal of Virology.
[76] Olivier Poch,et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy , 2011, Nature Medicine.